 TUCSON, Ariz., May 24, 2021 GLOBE NEWSWIRE -- HTG Molecular Diagnostics, Inc. Nasdaq: HTGM HTG, a life science company whose mission is to advance precision medicine, today announced that its HTG EdgeSeq technology is highlighted in several posters being presented at the American Society of Clinical Oncology ASCO conference, being held virtually from June 4-8, 2021. 